Emerging monoclonal antibodies as targeted innovative therapeutic approaches to asthma-Reference-Cited by-同舟云学术

Emerging monoclonal antibodies as targeted innovative therapeutic approaches to asthma

Published:2015-11-18 Issue:1 Volume:99 Page:38-48
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Mitchell PD¹,El-Gammal AI¹,O'Byrne PM¹

Affiliation:

1. Firestone Institute of Respiratory Health and the Department of Medicine, Michael G DeGroote School of Medicine, McMaster University; Hamilton Ontario Canada

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference103 articles.

1. The global burden of asthma: executive summary of the GINA Dissemination Committee report;Masoli;Allergy.,2004

2. Failure in asthma control: reasons and consequences;Braido;Scientifica.,2013

3. IL-17 polymorphisms and asthma risk: a meta-analysis of 11 single nucleotide polymorphisms;Jin;J. Asthma,2015

4. IL-9 governs allergen-induced mast cell numbers in the lung and chronic remodeling of the airways;Kearley;Am. J. Respir. Crit. Care Med.,2011

5. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma;Chung;Eur. Respir. J.,2014

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhaled drug delivery for the targeted treatment of asthma;Advanced Drug Delivery Reviews;2023-07

2. Nanocarriers for the treatment of inflammatory diseases;Green Sustainable Process for Chemical and Environmental Engineering and Science;2023

3. Experience of using dupilumab in the treatment of severe asthma;Terapevticheskii arkhiv;2020-09-03

4. Measuring and reporting treatment adherence: What can we learn by comparing two respiratory conditions?;British Journal of Clinical Pharmacology;2020-07-27

5. TSLP and IL‐33 reciprocally promote each other's lung protein expression and ILC2 receptor expression to enhance innate type‐2 airway inflammation;Allergy;2020-02-24